• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Turkey·Basic Materials·HEKTS.IS
Share

Hektas Ticaret T.A.S. Stocks

TRY 3.78Last Updated 22.05.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

TRY 708.61M

TRY 3.78
Key Takeaways

Risk factor

Weak & very vulnerable to price shocks

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Hektas Ticaret T.A.S. produces, imports, and markets agricultural and veterinary pesticides and fertilizers in Turkey. Its crop protection products include fungicides, herbicides, insecticides, acaricides, biological insecticides, fumigants, nematicides and soil fumigants, plant growth regulators, winter struggle medicines and summer oils, and spread adhesives. The company also offers leaf fertilizers, organ minerals, drip irrigation, and other products; and tomato seeds. In addition, it provides antibacterial, vitamin and mineral, feed additive, anti-inflammatory, and anti-parasite health products for animal; poultry health products; and pet care products and pet foods. Hektas Ticaret T.A.S. was founded in 1956 and is headquartered in Gebze, Turkey.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. Specifically, the stock is overvalued on EV/EBITDA, reasonably priced o

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of HEKTS.IS is 4.3 and suggests 12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendati

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

26.05.2026 20:47

Micron's capitalization reaches $1 trillion for the first time: UBS triples target price for its shares

26.05.2026 20:35

The son of Mango's founder is leaving the company. He is accused of involvement in his father's murder

26.05.2026 19:58

Eli Lilly will invest nearly $4 billion to buy three vaccine developers. Why would she do that?

26.05.2026 19:11

BP shares plummet after unexpected sacking of board chief

26.05.2026 18:56

US stocks rise: optimism about AI has overshadowed military risks

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026